Perioperative Management of Hytrin (Terazosin)
Hytrin (terazosin) does not need to be stopped before surgery and should be continued throughout the perioperative period.
Key Recommendation
- Continue terazosin through surgery without interruption. 1 Alpha-1 adrenergic blockers like terazosin are not included in any major perioperative medication management guidelines as requiring discontinuation, indicating they are considered safe to continue. 2, 3, 4
Rationale for Continuation
No withdrawal risk or rebound hypertension. Unlike beta-blockers or clonidine, alpha-1 blockers do not cause dangerous withdrawal phenomena when stopped abruptly. 5
Maintains blood pressure control. Continuing antihypertensive medications perioperatively reduces the risk of postoperative hypertension, which can lead to myocardial ischemia, acute heart failure, and cerebral complications. 6
Prevents BPH symptom exacerbation. For patients taking terazosin for benign prostatic hyperplasia, continuation prevents urinary retention and acute symptom worsening in the postoperative period. 1
Important Perioperative Considerations
First-Dose Hypotension Risk
Be aware of orthostatic hypotension potential. Terazosin can cause significant first-dose hypotension, particularly when therapy is restarted after interruption. 1 This is a key reason to avoid stopping the medication—restarting it postoperatively recreates this risk unnecessarily.
Monitor blood pressure closely. While continuation is recommended, anesthesiologists should be informed that the patient is taking an alpha-1 blocker, as these agents can potentiate intraoperative hypotension when combined with anesthetic agents. 7
Drug Interactions
Caution with calcium channel blockers. Terazosin administered concomitantly with verapamil or other antihypertensives may cause significant hypotension. 1 Ensure the anesthesia team is aware of all concurrent medications.
Caution with PDE-5 inhibitors. Hypotension has been reported when terazosin is used with phosphodiesterase-5 inhibitors (sildenafil, tadalafil). 1 Document any recent use of these medications.
Postoperative Management
Resume immediately when oral intake allowed. If the patient misses doses due to NPO status or surgical complications, resume terazosin as soon as oral medications are tolerated. 1
Restart at 1 mg if held for several days. The FDA label specifies that if terazosin is discontinued for several days or longer, therapy should be reinstituted using the initial 1 mg dosing regimen to minimize hypotensive risk. 1 This requirement for dose retitration is another strong argument for not stopping the medication in the first place.
Common Pitfalls to Avoid
Do not confuse with anticoagulants or antiplatelets. Major perioperative guidelines focus extensively on stopping anticoagulants (warfarin, DOACs) and antiplatelet agents (aspirin, clopidogrel) before surgery. 2, 3, 4, 8, 9 Terazosin is neither and requires no such interruption.
Do not stop "just to be safe." There is no evidence that continuing terazosin increases surgical bleeding risk or other perioperative complications. 5, 7 Stopping it creates unnecessary risks of rebound hypertension and BPH symptoms.
Distinguish from RAAS inhibitors. While debate exists about continuing ACE inhibitors and ARBs perioperatively (due to intraoperative hypotension concerns), 6, 10 this controversy does not apply to alpha-1 blockers like terazosin, which have a different mechanism and risk profile. 7